Current Grant Recipients

Grant recipients receive one to five year grants. Currently, JDRF is awarding over $12,200,000 in grant money to all of the researchers listed below.

Barbara Davis Center for Childhood Diabetes

JDRF is the largest charitable funder for diabetes research at the Barbara Davis Center.  Currently, we are funding 14 grants at the BDC which total $9.9 M and a total of  $2.9M annually.   Since the year 2000, JDRF has funded a total of $14.7M toward research at the BDC.

To see specific information on each grant please click on the researcher’s name.

Barbara Davis Center
Grant Recipients:

Andrea Steck, M.D.
Barbara Davis Center
Therapeutic Goal: Complications

Danny Zipris, Ph.D.
Barbara Davis Center
Therapeutic Goal: Autoimmunity – 4 projects

Dirk Homann, M.D.
Barbara Davis Center
Therapeutic Goal: Autoimmunity - 2 projects

George Eisenbarth, MD, Ph.D.
Barbara Davis Center
Therapeutic Goal: Molecular Studies

H. Peter Chase, M.D.
Barbara Davis Center
Therapeutic Goal: Complications

John Hutton, Ph.D.
Barbara Davis Center
Therapeutic Goal: Autoimmunity

Li Zhang, Ph.D.
Barbara Davis Center
Therapeutic Goal: Autoimmunity

Marian Rewers, M.D., Ph.D.
Barbara Davis Center
Therapeutic Goal: Autoimmunity – 2 projects

Peter Gottlieb, M.D.
Barbara Davis Center
Therapeutic Goal: Beta Cell Therapies

Raj Wadwa, M.D.
Barbara Davis Center
Therapeutic Goal: Complications

UCD Grant Recipients:

David Wagner, B.S., M.S., Ph.D.
University of Colorado Denver
Therapeutic Goal: Autoimmunity

Laurent Gapin, Ph.D.
University of Colorado Denver
Therapeutic Goal: Molecular Studies

Maki Nakayama, M.D.
University of Colorado Denver
Therapeutic Goal: T Cell Functions

Pierre Pirot, Ph.D.
University of Colorado Denver
Therapeutic Goal: Beta Cell Therapy

Ronald Gill, Ph.D.
University of Colorado Denver
Therapeutic Goal: Islet Cell Therapies

Thomas Delong, B.S., M.S., Ph.D.
University of Colorado Denver
Therapeutic Goal: Autoimmunity

Children’s Hospital Grant Recipient

Kristen Nadeau, M.D.
Children’s Hospital Denver
Therapeutic Goal: Metabolic Control